Ekaterina Iofina

Three‐year follow‐up after intracoronary beta‐radiation therapy for in‐stent restenosis

R. Blindt, R. Hoffmann, P. Radke, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Superiority of sirolimus eluting stent compared with intracoronary β radiation for treatment of in-stent restenosis: a matched comparison

R. Blindt, R. Hoffmann, P. Haager, 2005, Heart.

Advantage of sirolimus-eluting stents compared to intracoronary radiation therapy 30 months after treatment of in-stent restenosis.

R. Hoffmann, P. Radke, P. Hanrath, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

CORONARY ARTERY DISEASE Original Studies Sirolimus- and Paclitaxel-Eluting Stents in Comparison With Balloon Angioplasty for Treatment of In-Stent Restenosis

R. Blindt, R. Hoffmann, P. Haager, 2004 .

Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.

A. Schober, C. Weber, R. Hoffmann, 2005, The American journal of cardiology.

Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.

R. Blindt, R. Hoffmann, H. Kühl, 2006, The American journal of cardiology.

Sirolimus‐ and paclitaxel‐eluting stents in comparison with balloon angioplasty for treatment of in‐stent restenosis

R. Blindt, R. Hoffmann, P. Haager, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.